-
-
Until recently, an HIV and hepatitis C (HCV) coinfected patient who was managing well with HIV antiretrovirals might die from liver disease due to HCV infection. Now treatment has advanced, and the health prospects for coinfected patients are brighter than ever.
-
The key to a four-session HIV prevention for positives program targeting Latinos, called Positively Latino, is the adaptation of the theoretical model of motivational interviewing, which is a different approach than the traditional case management model.
-
The FDA has approved injectable poly-L-lactic acid, an injectable filler to correct facial fat loss in HIV patients.
-
The FDA has developed a web page to consolidate records of advisory committee meetings related to HIV/AIDS and associated conditions, making them easier to access.
-
-
Organizations successfully targeting Latino populations for HIV services and prevention have developed strategies specific to very different groups, including young men who have sex with men (MSM); rural, low-income Hispanics, and Latino migrants or Mexican border town residents.
-
A new study reports success in reducing risk and improving womens housing and employment status after enrollment in a woman-focused HIV intervention program.
-
The Centers for Disease Control and Prevention (CDC) is focusing on the role of physicians in its prevention for positives initiative, but according to one survey funded by the agency, the available prevention counseling is less than optimal.
-
While the latest reports show enrollment of children in SCHIP declined during the second half of 2003 the first enrollment decline since the program was enacted in 1997 the need for it remains great, and the American Academy of Pediatrics said more federal funding support for the program is needed.
